お知らせ • Jul 22
Altrova Health Inc. Announces Advisory Board Appointments Altrova Health Inc. announced that it is onboarding two new advisors to the advisory board: Jason Libenson and Blaise Yerly. Jason Libenson, President and Chief Operating Officer of Castlewood Capital Corporation, brings over ten years of experience in financial services, having held senior roles with several asset managers and raised capital across mutual funds, hedge funds, and flow-through fund structures. He has also served on the boards of various public companies. Mr. Libenson holds a Bachelor of Commerce from Concordia University and resides in Toronto. Blaise Yerly brings over 30 years of experience in Canadian public markets as both an investor and
director. He previously served as a director and Chairman of Aquiline Resources, acquired by Pan American Silver in 2009 for over $620 million in stock, and as a director of Treasury Metals (now NeXGold Mining) from 2008 to 2018 and Cypherpunk Holdings (now Sol Strategies Inc.) from 2017 to 2021. Mr. Yerly has served as Executive Chairman of Wacyba Ltd, a Swiss-based family holding company, since 2008, and has previously built and sold a heavy equipment distribution business in sub- Saharan Africa along with a related asset-based finance company. お知らせ • Jul 02
Altrova Health Inc. Announces Board Changes Altrova Health Inc. announced a transition in its Board of Directors leadership. Raf Souccar has resigned as Chairman and as a member of the Company's Board of Directors. The Company is grateful for Mr. Souccar's service and is pleased that he will continue to support Altrova Health in an advisory capacity going forward. The Board has appointed Tony Clement to serve as Chairman. Mr. Clement, who has served as a member of the Board, steps into this expanded leadership role at an important time for the Company. Mr. Clement's appointment as Chairman reflects the Board's deliberate focus on strengthening Altrova Health's leadership as the Company advances its healthcare portfolio. With a distinguished career spanning senior federal and provincial government roles, including experience in health policy, Mr. Clement brings perspective and relationships that the Board believes will be a meaningful asset to the Company at this stage of its development. The Honourable Tony Clement, P.C. is a former federal cabinet minister who served as Minister of Health, Minister of Industry, and President of the Treasury Board under Prime Minister Stephen Harper. He previously served as Ontario's Minister of Health and Long-Term Care under Premiers Mike Harris and Ernie Eves. Mr. Clement holds a law degree from the University of Toronto and has since held a number of board and advisory roles across the public and private sectors. お知らせ • Jun 05
Altrova Health Inc. Announces CFO Changes Altrova Health Inc. announced that effective on June 4, 2026, Greg Rossi has been appointed the new Chief Financial Officer (CFO) of the Company. Greg Rossi is a seasoned C-suite executive with more than 25 years of experience leading operations, supply chain, manufacturing, distribution, engineering, and business transformation initiatives across multiple industries. Having worked with global CPG and supply chain organizations while also leading and scaling high-growth companies in the e-commerce, SaaS, logistics, staffing, health, and cannabis sectors, Greg brings a wealth of expertise in operational leadership, strategic growth, and complex buy-side and sell-side transactions. His combination of operational depth and entrepreneurial leadership will be instrumental in driving Altrova Health's continued expansion and long-term shareholder value creation. Mr. Rossi will succeed outgoing CFO Jordan Greenberg. Jordan Greenberg, a seasoned financial executive with extensive public company experience, has brought strategic direction and financial discipline to Altrova Health since his appointment in December 2024. With a track record of success in scaling growth-stage businesses and deep knowledge of public markets, Jordan has been instrumental in strengthening the Company's financial reporting and operational foundations during a pivotal period of transition, including the Company's rebranding from Safe Supply Streaming Co. Ltd. to Altrova Health Inc. お知らせ • Jan 13
Safe Supply Streaming Co Ltd., Annual General Meeting, Mar 10, 2026 Safe Supply Streaming Co Ltd., Annual General Meeting, Mar 10, 2026. Location: british columbia, vancouver Canada お知らせ • Dec 11
Safe Supply Streaming Co Ltd. announced that it has received CAD 0.935 million in funding On December 11, 2025, Safe Supply Streaming Co Ltd. closed the transaction. The company issued 18,700,000 units at a price of CAD 0.05 per unit for gross proceeds of CAD 935,000. Each Unit consists of one common share of the Company and one-half of one warrant. Each whole warrant entitles the holder to purchase one additional Common Share at an exercise price of CAD 0.075 per share for a period of 24 months from the date of issuance. In connection with the Offering, the Company paid finder's fees on certain subscriptions in accordance with applicable securities laws and CSE policies, consisting of cash commissions of CAD 65,450 and 1,309,000 broker warrants in respect of investors introduced by eligible finders. Each broker warrant is exercisable to acquire one additional Unit at CAD 0.05 for a period of 24 months from the date of issuance. All securities issued in connection with the Offering are subject to a statutory hold period of four months plus one day from the date of issuance, in accordance with applicable Canadian securities laws. The transaction included participation from existing shareholders, members of the management team, new strategic investors and an insider of the Company. お知らせ • Nov 25
Safe Supply Streaming Co. Ltd. announced that it expects to receive CAD 0.5 million in funding Safe Supply Streaming Co. Ltd. announced a proposed non-brokered private placement of 10,000,000 units at an issue price of CAD 0.05 per unit for gross proceeds of CAD 500,000 on November 24, 2025. Each Unit consists of one common share and one-half of one common share purchase warrant with each Warrant exercisable for one Share at a price of CAD 0.075 per Share for two years from closing. In connection with the Offering, the Company may pay finders' fees of up to 7% cash and 7% broker's warrants exercisable for the purchase of one Unit at a price of $0.05 for a period of two years to eligible finders in connection with the Offering, subject to compliance with applicable securities laws and policies of the Canadian Securities Exchange. Closing of the Offering is subject to the Company obtaining all necessary corporate and regulatory approvals, including approval from the Canadian Securities Exchange. All securities issued in connection with the Offering will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation in Canada. 
